Loading interface...

Rosys FT (10/145 mg) Tablet

Manufactured bySystopic Laboratories Pvt. Ltd.
ContainsRosuvastatin (10 mg) + Fenofibrate (145 mg)
Description
Rosys FT (10/145 mg) Tablet is a combination medicine used for the treatment of combined hyperlipidemia (a high level of lipids (fats, cholesterol and triglycerides) circulating in the blood) in patients with normal kidney and liver function. It lowers the fatty substances (cholesterols and triglycerides) levels in the blood. These fatty substances build up in the blood vessels leading to narrowing or blockage of the vessels, causing an increased risk of heart disease, stroke, etc. Patients are advised to maintain a strict exercise and diet regimen along with this medicine for the best possible effect. The common side effects of Rosys FT (10/145 mg) Tablet are headache, stomach pain, excessive gas in the stomach, muscle pain, nausea and vomiting. Most of these side effects are mild and do not require medical attention as they may resolve with time. However, if any of these side effects persist or worsen, consult your doctor at the earliest. Do not take this medicine if you are allergic to it. You can take Rosys FT (10/145 mg) Tablet with food or on an empty stomach. Do not stop taking this medicine on your own even if you feel well. Discuss all the known illnesses such as liver diseases, kidney diseases, bleeding disorders, etc., with your doctor. Inform the doctor if you are pregnant, planning pregnancy or breastfeeding mother. Your doctor may advise you on some tests such as lipid profile, liver function, etc., to make sure this medicine is working properly.

Side effects

Major & minor side effects for Rosys FT (10/145 mg) Tablet

  • Muscle pain
  • Tenderness
  • Weakness
  • Headache
  • Joint pain
  • Acid or sour stomach (burps)
  • Diarrhoea
  • Excessive air or gas in stomach
  • Blood in urine
  • Chills and fever
  • Nausea and vomiting
  • Stuffy nose
  • Stomach pain

Uses of Rosys FT (10/145 mg) Tablet

What is it prescribed for?

  • Combined hyperlipidemia
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The actual time Rosys FT (10/145 mg) Tablet takes to show its effect is not known. However, you may start feeling well in a few days.
  • How long do the effects of this medicine last?
    The average time for which Rosys FT (10/145 mg) Tablet stays in the body is not known.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    Rosys FT (10/145 mg) Tablet has no habit forming tendency.
  • Can this medicine be taken during pregnancy?
    The use of Rosys FT (10/145 mg) Tablet in pregnancy is contraindicated as it may cause foetal death. Discuss all the potential benefits and risks with your doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    Rosys FT (10/145 mg) Tablet is known to pass into breastmilk. This medicine may damage the muscle, liver and kidneys of the infant. Your doctor may advise discontinuing either breastfeeding or medicine based on the clinical condition. Discuss all the benefits and risks before starting the therapy.

Allergy

Do not take Rosys FT (10/145 mg) Tablet if you have a known allergy to this medicine or any other inactive ingredients present along with the formulation. Seek medical attention if you come across any allergic reactions such as skin rash, hives, swelling (face, lips, tongue, etc.), breathing difficulty, etc.

Active liver disease

Taking Rosys FT (10/145 mg) Tablet in the patients suffering from liver disease may severely increase the hepatic transaminase enzyme levels in the body. It may cause severe side effects and also worsen the compromised liver. Hence, this medicine is not recommended to use in active liver disease patients.

Kidney disease

Taking Rosys FT (10/145 mg) Tablet in the patients suffering from kidney disease may severely increase the serum creatinine levels in the body. It may cause severe side effects and also worsen the condition of compromised kidneys. Hence, this medicine is not recommended to use in kidney disease.

Gallbladder disease

Taking Rosys FT (10/145 mg) Tablet in patients suffering from gall bladder disease may increase the risk of gall bladder stones. Hence, this medicine is not recommended to use in gallbladder disease.
Warnings for special population

Pregnancy

The use of Rosys FT (10/145 mg) Tablet in pregnancy is contraindicated as it may cause foetal death. Discuss all the potential benefits and risks with your doctor before taking this medicine.

Breast-feeding

Rosys FT (10/145 mg) Tablet is known to pass into breastmilk. This medicine may damage the muscle, liver and kidneys of the infant. Your doctor may advise discontinuing either breastfeeding or medicine based on the clinical condition. Discuss all the benefits and risks before starting the therapy.
General warnings

Cognitive impairment

Rosys FT (10/145 mg) Tablet may cause forgetfulness, memory loss, confusion, etc., in some patients. These side effects are reversible and usually disappear once the medicine is discontinued.

Altered blood sugar levels

Rosys FT (10/145 mg) Tablet may cause an alteration in the blood sugar levels. This risk is especially higher in patients with diabetes mellitus. Close monitoring of blood sugar levels may be necessary based on the clinical condition.

Alcohol consumption

Rosys FT (10/145 mg) Tablet may cause liver and kidney injuries in patients consuming alcohol very frequently and in large quantities. Hence, consumption of alcohol should be avoided during treatment with this medicine.

Use in children

The safety and efficacy of Rosys FT (10/145 mg) Tablet use in children younger than 6 years have not been studied.

Gall bladder stone

Rosys FT (10/145 mg) Tablet should be used with caution due to the increased risk of gallbladder stones (cholelithiasis). This risk is especially higher in patients with a history of liver or gallbladder diseases. Close monitoring of the clinical conditions is indicated.

Hematologic changes

Rosys FT (10/145 mg) Tablet should be used with caution due to the risk of a decrease in the haemoglobin, hematocrit, and white blood cell counts. Close monitoring of complete blood counts is recommended during treatment with this medicine.

Increase in serum creatinine levels

Close monitoring of kidney function is recommended in patients receiving Rosys FT (10/145 mg) Tablet due to the increased risk of elevated serum creatinine levels.

Missed Dose

Take the missed dose of Rosys FT (10/145 mg) Tablet as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume at the scheduled time. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case you suspect Rosys FT (10/145 mg) Tablet overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Leflunomide

Atazanavir

Cyclosporine

Gemfibrozil

Colchicine

Coumarin

Disease interactions

Diabetes

Caution should be exercised while using Rosys FT (10/145 mg) Tablet in patients with diabetes mellitus due to the increased risk of altered blood sugar levels. This medicine increases the blood sugar levels in the blood. Close monitoring of blood sugar levels is indicated for such patients.

Rhabdomyolysis

Caution should be exercised while using Rosys FT (10/145 mg) Tablet in patients with rhabdomyolysis (a serious condition in which there is a leakage of damaged muscle tissue in the blood, characterized by muscle weakness and tenderness) due to the increased risk of renal failure and death. Close monitoring of the clinical condition and kidney function test is indicated.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Rosys FT (10/145 mg) Tablet with food or on an empty stomach. Do not take in larger amounts than advised. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not self-medicate or stop on your own unless directed by your doctor. Do not crush, break or chew the tablet. Take the tablet immediately after peeling from the strip.
Miscelleneous

To be taken on an empty stomach

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Rosuvastatin reduces the production of cholesterol from the liver. Fenofibrate increases the natural lipid breakdown process with the help of the enzyme lipoprotein lipase. This removes the bad cholesterol (LDL) and triglycerides from the blood and increases the levels of good cholesterol (HDL).
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Statins, Fibric acid derivatives, Antihyperlipidemic combinations

Schedule

Schedule H

Go.drugbank.com. 2021. Rosuvastatin: Uses, Interactions, Mechanism of Action | DrugBank Online. [online] Available at: < [Accessed 9 July 2021].

https://go.drugbank.com/drugs/DB01098>

Go.drugbank.com. 2021. Fenofibrate: Uses, Interactions, Mechanism of Action | DrugBank Online. [online] Available at: < [Accessed 9 July 2021].

https://go.drugbank.com/drugs/DB01039>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 9 July 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021366s016lbl.pdf>

CiplaMed. 2021. ROSULIP-F Tablets. [online] Available at: < [Accessed 9 July 2021].

https://ciplamed.com/content/rosulip-f-tablets>

Drugs, H., 2021. Fenofibrate: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 9 July 2021].

https://medlineplus.gov/druginfo/meds/a601052.html>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 9 July 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021656s029lbl.pdf>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 12 Jul 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.